Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
In Vivo ; 38(2): 647-651, 2024.
Article in English | MEDLINE | ID: mdl-38418161

ABSTRACT

BACKGROUND/AIM: Non-steroidal anti-inflammatory drugs (NSAIDs), the most widely used pharmaceuticals, induce various adverse effects, including gastrointestinal injuries, such as ulcers and bleeding. Animal models of NSAID-induced small intestinal injury (NSI) have been extensively employed for the development of preventive and therapeutic agents. However, some experimental variations related to feeding times have been observed following NSI induction. This study aimed to investigate the impact of feeding time on an NSI mouse model. MATERIALS AND METHODS: The mice were divided into eight groups: normal, sham, and model groups (with feeding times of 2 h, 6 h, 10 h, 14 h, 18 h, and 22 h; n=10 in each group). The mice were fasted for 18 h before the injection of indomethacin (15 mg/kg, subcutaneously), except for the normal group. Food supply was halted at specific time points (2 h, 6 h, 10 h, 14 h, 18 h, and 22 h); however, the normal and sham groups were continuously fed throughout the experiment. The length of the small intestine was measured, and histological analysis was performed 24 h after induction. RESULTS: Up to 14 h after induction, NSI, indicated by small intestine shortening, remained consistent, with a reduction in length of approximately 10-20%. However, feeding for more than 14 h significantly exacerbated NSI, both anatomically and histologically. CONCLUSION: The ulcerative changes observed in the small intestine 14 h after indomethacin injection may be closely associated with the influence of food on NSI.


Subject(s)
Intestinal Diseases , Mice , Animals , Intestinal Diseases/chemically induced , Intestinal Diseases/pathology , Intestinal Diseases/prevention & control , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Indomethacin/adverse effects , Intestine, Small/pathology , Disease Models, Animal , Ulcer/pathology
2.
Front Neurol ; 12: 717513, 2021.
Article in English | MEDLINE | ID: mdl-34650505

ABSTRACT

To date, many studies using the controlled cortical impact (CCI) mouse model of traumatic brain injury (TBI) have presented results without presenting the pathophysiology of the injury-core itself or the temporal features of hemorrhage (Hrr). This might be owing to the removal of the injury-core during the histological procedure. We therefore developed a modified protocol to preserve the injury-core. The heads of mice were obtained after perfusion and were post-fixed. The brains were then harvested, retaining the ipsilateral skull bone; these were post-fixed again and sliced using a cryocut. To validate the utility of the procedure, the temporal pattern of Hrr depending on the impacting depth was analyzed. CCI-TBI was induced at the following depths: 1.5 mm (mild Hrr), 2.5 mm (moderate Hrr), and 3.5 mm (severe Hrr). A pharmacological study was also conducted using hemodynamic agents such as warfarin (2 mg/kg) and coagulation factor VIIa (Coa-VIIa, 1 mg/kg). The current protocol enabled the visual observation of the Hrr until 7 days. Hrr peaked at 1-3 days and then decreased to the normal range on the seventh day. It expanded from the affected cortex (mild) to the periphery of the hippocampus (moderate) and the brain ventricle (severe). Pharmacological studies showed that warfarin pre-treatment produced a massively increased Hrr, concurrent with the highest mortality rate and brain injury. Coa-VIIa reduced the side effects of warfarin. Therefore, these results suggest that the current method might be suitable to conduct studies on hemorrhage, hematoma, and the injury-core in experiments using the CCI-TBI mouse model.

3.
Appl Geogr ; 1352021 Oct.
Article in English | MEDLINE | ID: mdl-34621098

ABSTRACT

The importance of implementing green infrastructure (GI) for flood protection is supported by multiple substantial cross-sectional analyses. Yet, limited longitudinal research has been conducted which addresses how to maintain and improve the configuration of GI in order to minimize the cost of losses resulting from flooding. Structural damage from devastating storm events has repeatedly imposed substantial financial burdens on local governments in coastal regions. This study longitudinally examines the impacts of changes in GI patterns on flood damage cost in coastal Texas areas. Major flood events in the 36 Texan coastal watershed counties along the Gulf of Mexico were monitored from 2000 to 2017. Along with non-spatially weighted panel data models, we developed an advanced statistical model controlling for spatially correlated errors in flood loss and predicting flood loss with a set of time-series socioeconomic and environmental control variables. The results of the spatial panel data model reveal that long-term maintenance of larger, more irregular, more dispersed, less fragmented, and less connected patterns of GI will help to reduce county-level flood damage costs per capita over time. Most importantly, protecting larger patches within a closer proximity was found to be of the utmost importance for retaining the flood regulation services provided by GI. These findings suggest that planners and natural resource managers should enhance supportive land use policies to preserve existing GI and strategically locate new implementations in order to achieve long-term flood protection.

4.
Planta Med ; 85(3): 231-238, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30300905

ABSTRACT

Epimedii Herba (EH) has been used in traditional Asian medicine to treat hemiplegia following stroke. Icariin, its major active component, is used as a quality-control marker and for its various pharmacological effects. We hypothesized that icariin would show protective effects following traumatic brain injury (TBI). The TBI mouse model was induced using a controlled cortical impact method. Body weight, brain damage, motor function, and cognitive function were evaluated. Synaptogenesis markers were analyzed to investigate potential mechanisms of action. The animals were divided into six groups: sham, control, minocycline-treated group, and icariin-treated (3, 10, and 30 mg/kg, p. o.) groups. The icariin 30 mg/kg-treated group regained body weight at 7 and 8 d post TBI. Icariin 30 mg/kg- and 10 mg/kg-treated groups showed enhanced sensory-motor function at 8 d post TBI in rotarod and balance beam tests. Icariin-treated groups showed increased recognition index in the novel object recognition test at all doses and increased spontaneous alternation in the Y-maze test at 30 mg/kg. Icariin upregulated brain-derived neurotrophic factor, synaptophysin and postsynaptic density protein 95 expressions. However, no protective effects against brain damage or neuronal death were observed. The current results provide a basis for using icariin following TBI and suggest that it could be a candidate for the development of therapeutic agents for functional recovery after TBI.


Subject(s)
Brain Injuries, Traumatic/drug therapy , Flavonoids/therapeutic use , Neuronal Plasticity/drug effects , Neuroprotective Agents/therapeutic use , Animals , Brain-Derived Neurotrophic Factor/metabolism , Disease Models, Animal , Disks Large Homolog 4 Protein/metabolism , Dose-Response Relationship, Drug , Maze Learning/drug effects , Mice , Minocycline/therapeutic use , Motor Skills/drug effects , Synaptophysin/metabolism
5.
Cell Death Dis ; 9(11): 1125, 2018 11 12.
Article in English | MEDLINE | ID: mdl-30420654

ABSTRACT

Leucine-rich repeat kinase 2 (LRRK2), originally identified as a causative genetic factor in Parkinson's disease, is now associated with a number of pathologies. Here, we show that brain injury induces a robust expression of endogenous LRRK2 and suggest a role of LRRK2 after injury. We found that various in vitro and in vivo models of traumatic brain injury (TBI) markedly enhanced LRRK2 expression in neurons and also increased the level of hypoxia-inducible factor (HIF)-1α. Luciferase reporter assay and chromatin immunoprecipitation revealed direct binding of HIF-1α in LRRK2 proximal promoter. We also found that HIF-1α-dependent transcriptional induction of LRRK2 exacerbated neuronal cell death following injury. Furthermore, application of G1023, a specific, brain-permeable inhibitor of LRRK2, substantially prevented brain tissue damage, cell death, and inflammatory response and alleviated motor and cognitive defects induced by controlled cortical impact injury. Together, these results suggest HIF-1α-LRRK2 axis as a potential therapeutic target for brain injury.


Subject(s)
Brain Injuries, Traumatic/genetics , Cerebral Cortex/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/genetics , Transcription, Genetic , Animals , Apoptosis/drug effects , Apoptosis/genetics , Base Sequence , Brain Injuries, Traumatic/metabolism , Brain Injuries, Traumatic/pathology , Brain Injuries, Traumatic/prevention & control , Cerebral Cortex/drug effects , Cerebral Cortex/pathology , Female , Gene Expression Regulation , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/antagonists & inhibitors , Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/metabolism , Mice , Mice, Inbred ICR , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondria/pathology , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Neuroprotective Agents/pharmacology , Primary Cell Culture , Promoter Regions, Genetic , Protein Binding , Protein Kinase Inhibitors/pharmacology , Psychomotor Performance/drug effects , Signal Transduction
6.
J Ethnopharmacol ; 225: 198-201, 2018 Oct 28.
Article in English | MEDLINE | ID: mdl-30009978

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Dangguisusan (DGSS) is a widely used prescription for the treatment of traumatic injury in Korean medicine. AIM OF THE STUDY: To demonstrate the effects of DGSS on a mouse model of traumatic brain injury (TBI) for providing scientific evidence in clinical use. MATERIALS AND METHODS: TBI was induced in a mouse model using the controlled cortical impact method. Water extract of DGSS (50, 150, and 450 mg/kg) was administered twice a day for 8 d. Histological analyses were performed 8 d after TBI. Moreover, beam-walking, grip-strength, and novel object recognition (NOR) tests were conducted to evaluate the effects on motor function, muscle strength, and cognitive memory function, respectively. RESULT: DGSS inhibited body weight loss, hippocampal damage, and neuronal loss in the thalamic region. Furthermore, it reduced transverse time and foot faults in the beam-walking test at 3 d and increased the muscle strength in the grip-strength test at 3 and 8 d. It also improved the recognition index (%) in the NOR test. However, DGSS did not show protective effects against total damage. CONCLUSIONS: DGSS might improve sensory-motor and cognitive functions after TBI with partial protective effects against brain damage. The present findings provide a scientific basis for the clinical use of DGSS in TBI.


Subject(s)
Brain Injuries, Traumatic/drug therapy , Neuroprotective Agents/therapeutic use , Plant Extracts/therapeutic use , Animals , Behavior, Animal/drug effects , Disease Models, Animal , Hippocampus/drug effects , Male , Mice, Inbred ICR , Neurons/drug effects
7.
Cell Transplant ; 26(6): 1001-1016, 2017 06 09.
Article in English | MEDLINE | ID: mdl-28105979

ABSTRACT

We compared the therapeutic effects and mechanism of transplanted human dental pulp stem cells (hDPSCs) and human bone marrow-derived mesenchymal stem cells (hBM-MSCs) in a rat stroke model and an in vitro model of ischemia. Rats were intravenously injected with hDPSCs or hBM-MSCs 24 h after middle cerebral artery occlusion (MCAo), and both groups showed improved functional recovery and reduced infarct volume versus control rats, but the hDPSC group showed greater reduction in infarct volume than the hBM-MSC group. The positive area for the endothelial cell marker was greater in the lesion boundary areas in the hDPSC group than in the hBM-MSC group. Administration of hDPSCs to rats with stroke significantly decreased reactive gliosis, as evidenced by the attenuation of MCAo-induced GFAP+/nestin+ and GFAP+/Musashi-1+ cells, compared with hBM-MSCs. In vivo findings were confirmed by in vitro data illustrating that hDPSCs showed superior neuroprotective, migratory, and in vitro angiogenic effects in oxygen-glucose deprivation (OGD)-injured human astrocytes (hAs) versus hBM-MSCs. Comprehensive comparative bioinformatics analyses from hDPSC- and hBM-MSC-treated in vitro OGD-injured hAs were examined by RNA sequencing technology. In gene ontology and KEGG pathway analyses, significant pathways in the hDPSC-treated group were the MAPK and TGF-ß signaling pathways. Thus, hDPSCs may be a better cell therapy source for ischemic stroke than hBM-MSCs.


Subject(s)
Bone Marrow Cells/cytology , Brain Ischemia/therapy , Dental Pulp/cytology , Mesenchymal Stem Cells/cytology , Stem Cells/cytology , Animals , Disease Models, Animal , Graft Rejection , Humans , Immunity, Innate/physiology , In Situ Nick-End Labeling , Macrophages/cytology , Macrophages/physiology , Mesenchymal Stem Cells/physiology , Neutrophils/cytology , Neutrophils/physiology , Retinal Pigment Epithelium/cytology , Stem Cells/physiology , T-Lymphocytes/cytology , T-Lymphocytes/physiology
8.
Mediators Inflamm ; 2014: 417814, 2014.
Article in English | MEDLINE | ID: mdl-24948848

ABSTRACT

Inflammatory bowel disease (IBD) is a chronically relapsing inflammatory disorder of the gastrointestinal tract. Most IBD treatments are unsatisfactory; therefore, various dietary supplements have emerged as promising interventions. Laminaria japonica (LJ) is an edible seaweed used to regulate digestive symptoms. Probiotics have been reported to improve digestive problems and their simultaneous administration with seaweeds has been shown to produce synergistic therapeutic effects. Here, we investigated the effect of LJ combination with probiotics on dextran sodium sulfate-induced colitis model in mice. Aqueous LJ extracts (LJE) at doses from 100 to 300 mg/kg and probiotics at a dose of 300 mg/kg were orally administered for 7 days. Body weight, colon length, histological score, macroscopic damage, and the levels of cytokines IFN- γ , IL-1 ß , IL-6, IL-10, IL-12 (P40), IL-12 (P70), IL-17, and TNF- α were assessed. LJE alone caused a significant improvement of colitis signs such as colon length, histological score, and IL-1 ß and IL-6 production. LJE and probiotics demonstrated a synergistic effect by the histological score and levels of IL-1 ß , IL-6, and IL-12 (P40) but not IFN- γ , IL-10, and IL-12 (P70). In conclusion, LJE was effective in inducing protection against colitis in mice and acted synergistically with probiotics.


Subject(s)
Colitis/chemically induced , Colitis/prevention & control , Laminaria/immunology , Probiotics/administration & dosage , Seaweed/chemistry , Animals , Body Weight , Colon/pathology , Cytokines/metabolism , Dextran Sulfate/pharmacology , Gastrointestinal Tract , Inflammation , Male , Mice , Mice, Inbred BALB C , Temperature
9.
J Med Food ; 16(10): 953-6, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24063406

ABSTRACT

Nutmeg (seed of Myristica fragrans [MF]) is one of the most commonly used spices in the world and also a well-known herb for the treatment of various intestinal diseases, including colitis in traditional Korean medicine. The purpose of the current study was to investigate whether water extract of MF (MFE) can protect against dextran sulfate sodium (DSS) induced colitis in a mouse model. Colitis was induced by 5% DSS in balb/c mice. MFE (100, 300 or 1000 mg/kg) was orally administered to the mice twice a day for 7 days. Body weight, colon length, clinical score, and histological score were assessed to determine the effects on colitis. Proinflammatory cytokines (interferon-γ, tumor necrosis factor-α, interleukin [IL]-1ß, and IL-6) were measured to investigate the mechanisms of action. MFE dose dependently inhibited the colon shortening and histological damage to the colon. However, it did not prevent weight loss. MFE also inhibited proinflammatory cytokines. The current results suggest that MFE ameliorates DSS-induced colitis in mice by inhibiting inflammatory cytokines. Further investigation, including the exact mechanisms is needed.


Subject(s)
Colitis/drug therapy , Gastrointestinal Agents/administration & dosage , Myristica/chemistry , Plant Extracts/administration & dosage , Animals , Colitis/chemically induced , Colitis/immunology , Cytokines/immunology , Dextran Sulfate/adverse effects , Disease Models, Animal , Humans , Male , Mice , Mice, Inbred BALB C , Seeds/chemistry
10.
Br J Nutr ; 109(2): 283-92, 2013 Jan 28.
Article in English | MEDLINE | ID: mdl-22569277

ABSTRACT

Inflammatory bowel diseases (IBD) are chronically relapsing inflammatory disorders of the intestine. Although some therapeutic agents, including steroids, are available for the treatment of IBD, these agents have limited use. Therefore, dietary supplements have emerged as possible interventions for IBD. Japanese honeysuckle flower, the flower of Lonicera japonica, is a well-known dietary supplement and has been used to prevent or treat various inflammatory diseases. In the present study, we investigated the effects of L. japonica on experimental murine colitis. Colitis was induced by 5 % dextran sulphate sodium (DSS) in Balb/c mice. The water extract of L. japonica (LJE) at doses of 20, 100 or 500 mg/kg was orally administered to mice twice per day for 7 d. Body weight, colon length and a histological damage score were assessed to determine the effects on colitis. Cytokine profiles were assessed to examine the effects on helper T (Th) cell-related immunological responses. In addition, CD4⁺CD25⁺Foxp3⁺T cells were analysed in vivo and in vitro for investigating the effects on regulatory T (Treg) cells. LJE showed dose-dependent inhibitory effects against colon shortening, weight loss and histological damage. LJE down-regulated IL-1ß, TNF-α, interferon-γ, IL-6, IL-12 and IL-17. However, LJE did not show any significant effects on IL-10, IL-23, transforming growth factor-ß1 and Treg cell populations. In conclusion, LJE showed protective effects against DSS-induced colitis via the Th1/Th17 pathway and not via Treg cell-related mechanisms.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Colitis/prevention & control , Dietary Supplements , Lonicera/chemistry , Plant Extracts/therapeutic use , Th1 Cells/immunology , Th17 Cells/immunology , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Colitis/immunology , Colitis/pathology , Colon/immunology , Colon/pathology , Dextran Sulfate , Dietary Supplements/analysis , Disease Models, Animal , Down-Regulation , Flowers/chemistry , Inflammatory Bowel Diseases/immunology , Inflammatory Bowel Diseases/pathology , Inflammatory Bowel Diseases/prevention & control , Intestinal Mucosa/immunology , Intestinal Mucosa/pathology , Male , Medicine, East Asian Traditional , Mice , Mice, Inbred BALB C , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Random Allocation , Republic of Korea , T-Lymphocytes, Regulatory/immunology
11.
Eur J Pharmacol ; 689(1-3): 89-95, 2012 Aug 15.
Article in English | MEDLINE | ID: mdl-22659584

ABSTRACT

Chlorogenic acid (CGA) has been reported to have various beneficial effects on the cardiovascular and central nervous systems. The purpose of the current study was to investigate whether CGA has protective effects against cerebral ischemia and whether these effects are due to modification of brain edema-related vascular factors. In a rat model of transient middle cerebral artery occlusion (MCAo, 2h of occlusion followed by 22 h of reperfusion), we measured infarct volume and performed behavioral test to evaluate the effects of CGA on brain damage and sensory-motor functional deficits. Brain water content and Evans blue extravasation were measured to evaluate brain edema and blood brain barrier (BBB) damage. Lipid peroxidation (LPO) and the expressions and activities of matrix metalloproteinase (MMP)-2 and MMP-9 were measured to investigate the mechanisms of action. Intraperitoneal injection of CGA (3, 10, and 30 mg/kg) at 0 h and 2h after MCAo dose-dependently reduced infarct volume and sensory-motor functional deficits. It also reduced brain water content and Evans blue extravasation. Mechanistically, CGA reduced LPO and MMPs expressions and activities. These results suggest that CGA reduces brain damage, BBB damage and brain edema by radical scavenging activity and the inhibitory effects on MMP-2 and MMP-9.


Subject(s)
Brain Edema/drug therapy , Brain Ischemia/drug therapy , Chlorogenic Acid/therapeutic use , Disease Models, Animal , Matrix Metalloproteinase 2 , Matrix Metalloproteinase 9 , Matrix Metalloproteinase Inhibitors/therapeutic use , Animals , Brain Edema/enzymology , Brain Edema/pathology , Brain Ischemia/enzymology , Brain Ischemia/pathology , Chlorogenic Acid/pharmacology , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase Inhibitors/pharmacology , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Rats , Rats, Sprague-Dawley
12.
Phytother Res ; 26(10): 1521-7, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22322923

ABSTRACT

Brain oedema is the volumetric increase of brain tissue and is known to be linked to vascular factors, including the blood-brain barrier (BBB) and vascular permeability. Besides neuroprotection, inhibition of brain oedema also can be a method to protect the brain against ischaemic insult. Sesame is reported to have various beneficial effects on the cardiovascular and cerebrovascular systems. The neuroprotective effects of defatted sesame seed extract (DSE) in a transient middle cerebral artery occlusion (tMCAo) rat model were reported previously. The current study was planned to investigate whether the neuroprotective effects of DSE is related to brain oedema. The tMCAo rat model was used to investigate the brain water content (BWC) and Evans blue (EB) leakage. Aquaporin 4 (AQP4), matrix metalloproteinase (MMP)-2 and MMP-9 expressions at 4 and 24 h after ischaemia were analysed. In vitro zymography was performed to investigate the effects on MMPs activities. DSE (30, 100, and 300 mg/kg, p.o.) reduced BWC but not EB leakage. DSE inhibited AQP4 expression at 4 h but not at 24 h after ischaemia. It did not show any effects on MMPs expressions and activities. Therefore, DSE might be effective on brain oedema by AQP4 regulation during the acute phase of ischaemia.


Subject(s)
Aquaporin 4/metabolism , Brain Edema/drug therapy , Ischemic Attack, Transient/drug therapy , Plant Extracts/pharmacology , Seeds/chemistry , Sesamum/chemistry , Animals , Male , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...